Description

n-[(2Z)-4,5-Dimethyl-1,3-Thiazol-2(3H)-Ylidene]-2-[3-(Morpholin-4-Yl)-6-Oxopyridazin-1(6H)-Yl]Acetamide is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a key heterocyclic scaffold for creating targeted therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new drugs in areas such as oncology and neurology.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize the potency and selectivity of lead compounds.
• API Development: Integral in the process development and scale-up of new active pharmaceutical ingredients for preclinical and clinical trials.
• Biochemical Probe Synthesis: Employed to create specialized molecules for investigating biological mechanisms and target validation.
• Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.

Basic Information

Product Name	n-[(2Z)-4,5-Dimethyl-1,3-Thiazol-2(3H)-Ylidene]-2-[3-(Morpholin-4-Yl)-6-Oxopyridazin-1(6H)-Yl]Acetamide
CAS No.	1282103-83-6
Molecular Formula	C17H21N5O3S
Molecular Weight	375.45 g/mol
Synonyms	2-[(4,5-Dimethyl-1,3-thiazol-2-yl)imino]-2-[3-(morpholin-4-yl)-6-oxo-1,6-dihydropyridazin-1-yl]acetamide; 2-[3-(Morpholin-4-yl)-6-oxopyridazin-1(6H)-yl]-N-(4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)acetamide; (Z)-2-(3-Morpholino-6-oxopyridazin-1(6H)-yl)-N-(4,5-dimethylthiazol-2(3H)-ylidene)acetamide; Acetamide, N-[(2Z)-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene]-2-[3-(4-morpholinyl)-6-oxo-1(6H)-pyridazinyl]-; CAS 1282103-83-6
EINECS	Contact for details

Quality Control

Our n-[(2Z)-4,5-Dimethyl-1,3-Thiazol-2(3H)-Ylidene]-2-[3-(Morpholin-4-Yl)-6-Oxopyridazin-1(6H)-Yl]Acetamide is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are provided and available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a dry environment and handled under conditions that minimize exposure to ambient light and humidity to maintain stability and purity.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.